Risk assessment and genetic counseling for Lynch syndrome - Practice resource of the National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.

Spring Holter, Michael J Hall, Heather Hampel, Kory Jasperson, Sonia S Kupfer, Joy Larsen Haidle, Maureen E Mork, Selvi Palaniapppan, Leigha Senter, Elena M Stoffel, Scott M Weissman, Matthew B Yurgelun

Journal: Journal of genetic counseling 2022;31(3):568-583

PMID: 35001450

Abstract

Identifying individuals who have Lynch syndrome involves a complex diagnostic workup that includes taking a detailed family history and a combination of various tests such as immunohistochemistry and/or molecular which may be germline and/or somatic. The National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer have come together to publish this practice resource for the evaluation of Lynch syndrome. The purpose of this practice resource was to provide guidance and a testing algorithm for Lynch syndrome as well as recommendations on when to offer testing. This practice resource does not replace a consultation with a genetics professional. This practice resource includes explanations in support of this and a summary of background data. While this practice resource is not intended to serve as a review of Lynch syndrome, it includes a discussion of background information and cites a number of key publications which should be reviewed for a more in-depth understanding. This practice resource is intended for genetic counselors, geneticists, gastroenterologists, surgeons, medical oncologists, obstetricians and gynecologists, nurses, and other healthcare providers who evaluate patients for Lynch syndrome.

© 2022 National Society of Genetic Counselors.

Address: Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Clinical Genetics, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Ambry Genetics, Aliso Viejo, California, USA.; Section of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Chicago, Chicago, Illinois, USA.; North Memorial Health Cancer Center, Minneapolis, Minnesota, USA.; Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Variantyx, Inc, Framingham, Massachusetts, USA.; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.; Chicago Genetic Consultants, LLC, Northbrook, Illinois, USA.; Genome Medical, South San Francisco, California, USA.; Dana-Farber Cancer Institute, Harvard Medical School, and Brigham and Women's Hospital, Boston, Massachusetts, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.